Notice of Results

Source: RNS
RNS Number : 3378E
Gelion PLC
10 March 2022

Gelion plc

("Gelion" or the "Company")

Notice of Interim Results and Investor Presentation

Gelion (AIM: GELN), the Anglo-Australian battery storage innovator, is pleased to announce that that it will publish its interim results for the six months ended 31 December 2021 on 16th March 2022.

On the day, Dr Steve Mahon (Chairman), Hannah McCaughey (CEO) and Amit Gupta (CFO) will host a live investor presentation via Investor Meet Company ("IMC") at 9:30am GMT.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the IMC dashboard up until 9am the day before the meeting (15 March 2022) or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet Gelion via: 

Investors who already follow Gelion on the IMC platform will automatically be invited.



Gelion plc

Hannah McCaughey, CEO

Thomas Maschmeyer, Founder and Principal Technology Advisor

Marcus Strom, Corporate Communications


via Alma PR

finnCap Ltd (Nominated Adviser and Sole Broker)

+44 207 220 0500

Corporate Finance

Christopher Raggett

Seamus Fricker

Fergus Sullivan



Barney Hayward



Alma PR (Financial PR Adviser)

Justine James

Josh Royston

Hannah Campbell

+44 20 3405 0205



Notes to editors

Gelion (AIM: GELN) is a publicly listed company on the London Stock Exchange AIM market. It was founded as a spin-out from the University of Sydney in 2015 by Professor Thomas Maschmeyer, one of the world's leading chemists who was awarded the Australian Prime Minister's Prize for Innovation 2020.

Gelion is a global renewable-energy storage innovator. By designing leading-edge battery technology for stationary and mobile energy, the Company supports the transition to a sustainable economy while delivering value for customers and investors.

·       The Gelion Endure battery uses low-cost, abundant raw materials and is based on a chemistry that is highly resistant to     fire.

·    The batteries are scalable, using lead-acid battery manufacturing technology, and the Company expects to develop   megawatt-hour capacity for large-scale infrastructure, including for solar and wind farms.

·       With applications in agriculture, mining, water management and irrigation the battery is highly adaptable for off-grid use.

In addition to investing in the growth of its zinc-bromide technology, the Company will use funding to develop its mobile energy division to enhance existing lithium-ion and lithium-sulfur battery technologies used in electric vehicles and the emerging market in electric aviation.

For the mobile market, Gelion's technology pipeline includes:

·       Highly tuneable, low-cost silicon nanoparticle additives for next-generation advanced lithium-ion batteries, which are         safer and have higher energy density. 

·       A low-cost additive, which increases the lifetime of lithium-sulfur batteries by more than four times, delivering up to three times higher energy by weight than conventional lithium-ion batteries.

Using additive technology developed by its R&D team, which cooperates closely with scientists at the School of Chemistry and the University of Sydney Nano Institute, Gelion will develop and license additives for advanced lithium-silicon and lithium-sulfur technologies for ultra-high-density batteries to extend the cycle-life and safety of mobile energy storage.

Gelion also recently announced a partnership with Battery Energy Power Solutions in Sydney to manufacture and distribute its zinc-bromide batteries for the Australian market.

Gelion qualified for the LSE Green Economy Mark which recognises London-listed companies and funds that derive more than 50% of their revenues from products and services that are contributing the environmental objectives such as climate change mitigation and adaptation, waste and pollution reduction, and the circular economy.  

To find out more, please visit:

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.